Back to Market Feed

Product Information

FOSFOMYCIN 3 GM SACHET is a generic product labeled by Cipla USA Inc., priced at $26.7542 per EA under NDC 69097057967. Its NADAC has been published 211 times since Aug 10, 2022.

FDA first approved this application on Jan 26, 2022. Its Orange Book therapeutic-equivalence code is AA.

FOSFOMYCIN 3 GM SACHET

FOSFOMYCIN TROMETHAMINE
$26.7542per EA

Strength

3 g/1

Manufacturer

Cipla USA Inc.

NDC

69097057967

Classification

Generic

Dosage Form

GRANULE, FOR SOLUTION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

FOSFOMYCIN TROMETHAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA211881

FDA Approved

1/26/2022

TE Code

AA

On Market Since

1/26/2022

Price Statistics

The NADAC for FOSFOMYCIN 3 GM SACHET has been published 211 times since Aug 10, 2022, and over the history we have for it it has declined 56.5%. The table below summarizes its recorded NADAC range and movement.

Current price$26.7542 per EA
All-time high$61.5000 (Aug 10, 2022)
All-time low$26.7542 (Aug 19, 2026)
52-week high$40.0458
52-week low$26.7542
Median price$41.9194
Average price$43.8623
Largest weekly change-35.0% (Apr 17, 2024)
Weeks tracked211
Tracking sinceAug 10, 2022

Price History

1W

-4.2%

1M

-4.2%

3M

-15.4%

6M

-25.5%

1Y

-33.2%

3Y

-39.3%

5Y

N/A

All

-56.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FOSFOMYCIN TROMETHAMINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of FOSFOMYCIN 3 GM SACHET?

The current National Average Drug Acquisition Cost (NADAC) for FOSFOMYCIN 3 GM SACHET, manufactured by Cipla USA Inc., is $26.7542 per EA (NDC 69097057967), effective Aug 19, 2026.

How has the price of FOSFOMYCIN 3 GM SACHET changed over time?

Over the history we have for it, the NADAC for FOSFOMYCIN 3 GM SACHET has declined 56.5%. It has been tracked across 211 weekly CMS publications since Aug 10, 2022.

What are the highest and lowest recorded NADAC prices for FOSFOMYCIN 3 GM SACHET?

Since Aug 10, 2022, the NADAC for FOSFOMYCIN 3 GM SACHET has ranged from a low of $26.7542 (Aug 19, 2026) to a high of $61.5000 (Aug 10, 2022), with a median of $41.9194 per EA.

Are there cheaper alternatives to FOSFOMYCIN 3 GM SACHET?

No other NADAC-published product currently shares the active ingredient and strength of FOSFOMYCIN 3 GM SACHET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures FOSFOMYCIN 3 GM SACHET?

FOSFOMYCIN 3 GM SACHET (NDC 69097057967) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.